New Data Unveiled for Bocunebart, a Promising Migraine Preventive Targeting a Novel Pathway Munich, Germany – June 29, 2026 –…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
For millions worldwide, the diagnosis of actinic keratoses (AK) initiates a challenging journey to prevent the progression to skin cancer.…
Read More
DNA Aptamers Offer a Promising New Frontier in Identifying and Targeting Senescent Cells for Aging and Disease Research
One of the most significant hurdles in unraveling the complexities of aging and a spectrum of diseases lies in the…
Read More
Vedana Therapeutics Secures $46 Million Series A to Advance Next-Generation Migraine Prevention Therapies Targeting PACAP
Seattle-based biotech firm Vedana Therapeutics has successfully closed a $46 million Series A financing round, a significant infusion of capital…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
Rubedo Life Sciences, an AI-driven biotech startup focused on longevity, has announced positive preliminary results from its Phase 1b/2a study…
Read More
Cornell University Researchers Develop Breakthrough Nonhormonal Male Contraceptive Targeting Cellular Meiosis
In a landmark achievement for reproductive science, researchers at Cornell University have announced a significant advancement in the pursuit of…
Read More
Cornell University Scientists Identify New Pathway for Reversible Nonhormonal Male Contraceptive Targeting Meiosis
In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant breakthrough in the quest for…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
For millions globally afflicted by actinic keratoses (AKs), the rough, scaly patches of sun-damaged skin that serve as precursors to…
Read More
CBD Shows Promise in Mitigating Neuroinflammation and Targeting Alzheimer’s Disease Progression
New clinical insights published in the journal eNeuro suggest that cannabidiol (CBD), a non-psychoactive compound derived from the cannabis plant,…
Read More
A Novel Drug Screening Platform Revolutionizes Approach to Neurological and Psychiatric Disorders by Targeting Protein Expression Imbalances
Researchers have developed an innovative drug screening platform designed to identify compounds that precisely target the primary cause of numerous…
Read More
